Drugs / Bronchial basal cells (BBCs)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03655808 | Jun 2020 → May 2023 | bronchiectasis | Ruijin Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bronchial basal cells (BBCs) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03655808 ↗ |
| Modality | Cell therapy | “autologous P63+ progenitor cell transplantation” PMID 39566467 ↗ Nov 2024 |
| Route | Other | “qualified BBCs will be injected directly into the lesion by fiberoptic bronchoscopy after airway clearance.” NCT03655808 ↗ |